| Literature DB >> 31775707 |
Weiwei Li1,2, Zheng Liu1,3, Xiao Xiao1,3, Zhen Zhang1,3, Xiyang Wang4,5.
Abstract
BACKGROUND: The surgical procedures for mid-thoracic spinal tuberculosis mainly include anterior transthoracic debridement and fusion and posterior transpedicular debridement and fusion. Until now, the surgical choice is still controversial. This study aims to compare the clinical efficacy of anterior transthoracic debridement and fusion with posterior transpedicular debridement and fusion in the treatment of mid-thoracic (T5-9) spinal tuberculosis in adult patients.Entities:
Keywords: Anterior; Posterior; Spinal tuberculosis; Thoracic; Transpedicular; Transthoracic
Mesh:
Year: 2019 PMID: 31775707 PMCID: PMC6882028 DOI: 10.1186/s12891-019-2945-x
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Fig. 1A 49-year-old female patient with T7–8 spinal tuberculosis received anterior transthoracic debridement and fusion. 1a–1c Preoperative images showed paravertebral abscess formation in T7–8 and bone destruction in anterior column T8. 1d Intraoperative findings showed that the screws and titanium rod fixation were in place after interbody grafting with direct visual observation. (1e-g). Postoperative images after two weeks of operation showed that the interbody graft and instrumentation were in place. 1 h Postoperative images after 24 months of operation showed that solid interbody fusion was obtained
Fig. 2A 48-year-old female patient with T6–7 spinal tuberculosis received posterior transpedicular debridement and fusion. 2a–2d Preoperative images showed paravertebral abscess formation in T6–7 and bone destruction in vertebral body of T6 and T7. 1e Intraoperative findings showed that interbody grafting was carried out after removal of pedicles with direct visual observation. 2e-g Postoperative images after two weeks of operation showed that the instrumentation was in place. 1 h Postoperative images after 24 months of operation showed that solid interbody fusion was obtained
Basic clinical data of patients
| Group A ( | Group B ( | ||
|---|---|---|---|
| Gender (male/female) | 22/17 | 30/18 | 0.565 |
| Age (years) | 35.1 ± 8.4 | 37.2 ± 7.9 | 0.242 |
| Disease duration (months) | 9.6 ± 2.4 | 8.9 ± 2.3 | 0.234 |
| Number of affected segments | 1.2 ± 0.41 | 1.3 ± 0.45 | 0.482 |
| Pre-ESR (mm/h) | 53.3 ± 7.7 | 51.1 ± 6.8 | 0.153 |
| Pre-CRP (mg/L) | 31.9 ± 6.7 | 29.6 ± 7.9 | 0.149 |
| Pre-VAS score | 4.7 ± 1.0 | 4.4 ± 0.68 | 0.082 |
| Pre-Kyphosis angle | 21.0 ± 5.1 | 22.6 ± 3.0 | 0.09 |
Data are presented as n (%) or mean ± standard deviation (range)
Evaluation indexes Comparison between Group A and Group B
| Evaluation indexes | Group A (N = 39) | Group B (N = 48) | |
|---|---|---|---|
| Operation time (min) | 158.2 ± 10.7 | 183.7 ± 14.1 | 0.000 |
| Blood loss (ml) | 517.9 ± 76.5 | 714.6 ± 57.4 | 0.000 |
| Time of ESR descending to normal (months) | 2.3 ± 1.1 | 3.1 ± 1.4 | 0.000 |
| Time of CRP descending to normal (months) | 1.1 ± 0.3 | 1.2 ± 0.6 | 0.000 |
| Time of abscess disappearance (months) | 2.7 ± 1.6 | 4.9 ± 1.9 | 0.000 |
| Time of bone graft fusion (months) | 6.6 ± 0.8 | 8.0 ± 9.6 | 0.000 |
| Rate of surgical complications(%) | 7.7 (3/39) | 14.6 (7/48) | 0.370 |
| VAS score in postoperative 5th year | 1.0 ± 0.6 | 1.1 ± 0.4 | 0.449 |
| Kyphosis angle in postoperative 5th year | 9.9 ± 2.1 | 10.3 ± 1.9 | 0.266 |
Data are presented as n (%) or mean ± standard deviation (range)
SF-36 Scores of Comparison between Group A and Group B
| Group A | Group B | |||
|---|---|---|---|---|
| Pre-op | PF | 64.0 ± 5.3 | 65.4 ± 6.3 | 0.259 |
| RP | 14.7 ± 13.7 | 15.1 ± 16.1 | 0.912 | |
| BP | 43.5 ± 8.6 | 41.6 ± 9.0 | 0.305 | |
| GH | 26.4 ± 14.6 | 24.6 ± 11.9 | 0.538 | |
| VT | 45.6 ± 11.0 | 44.8 ± 11.7 | 0.729 | |
| SF | 27.9 ± 9.3 | 26.6 ± 8.0 | 0.495 | |
| RE | 35.9 ± 16.0 | 34.0 ± 16.1 | 0.591 | |
| MH | 29.5 ± 11.5 | 31.0 ± 11.5 | 0.532 | |
| Post-op 5th Year | PF* | 81.1 ± 5.9 | 82.9 ± 5.6 | 0.152 |
| RP* | 88.0 ± 15.5 | 92.3 ± 14.2 | 0.186 | |
| BP* | 86.0 ± 6.6 | 87.2 ± 7.2 | 0.420 | |
| GH* | 80.0 ± 12.5 | 81.8 ± 13.3 | 0504 | |
| VT* | 88.1 ± 6.1 | 78.8 ± 8.7 | 0.211 | |
| SF* | 76.6 ± 7.6 | 86.6 ± 5.1 | 0.194 | |
| RE* | 88.8 ± 15.9 | 89.7 ± 15.6 | 0.802 | |
| MH* | 82.1 ± 9.4 | 84.1 ± 11.6 | 0.374 |
PF Physical Functioning, RP Role-Physical, BP Bodily Pain, GH General Health, VT Vitality, SF Social Functioning, RE Role- Emotional, MH Mental Health
Pre-op pre-operation, Post-op post-operation
*: P < 0.05, compared with pre-op indexes